<!DOCTYPE html>
<html lang="en">

<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Lesson 3.5: The NAD+ Connection: Fueling the Longevity Engine</title>
    <style>
        /* Base & Reset */
        * {
            box-sizing: border-box;
        }

        body {
            font-family: Georgia, 'Times New Roman', serif;
            line-height: 1.8;
            color: #2d2d2d;
            background: #f8f6f3;
            margin: 0;
            padding: 0;
        }

        /* Main Container */
        .lesson-container {
            max-width: 860px;
            margin: 0 auto;
            padding: 40px 30px;
            background: #ffffff;
            min-height: 100vh;
            box-shadow: 0 0 60px rgba(0, 0, 0, 0.08);
        }

        /* Brand Header */
        .brand-header {
            text-align: center;
            padding-bottom: 30px;
            margin-bottom: 35px;
            border-bottom: 1px solid #eee;
        }

        .brand-logo {
            max-width: 220px;
            height: auto;
            margin-bottom: 5px;
        }

        /* Module Header - BLUE/GOLD theme for Longevity/Vascular */
        .module-header {
            background: linear-gradient(135deg, #1e3a8a 0%, #3b82f6 100%);
            padding: 35px 35px 30px;
            border-radius: 16px;
            margin-bottom: 30px;
            position: relative;
            overflow: hidden;
        }

        .module-header::before {
            content: '';
            position: absolute;
            top: 0;
            right: 0;
            width: 300px;
            height: 300px;
            background: radial-gradient(circle, rgba(255, 255, 255, 0.1) 0%, transparent 70%);
            transform: translate(100px, -100px);
        }

        .module-header::after {
            content: '';
            position: absolute;
            bottom: 0;
            left: 0;
            width: 100%;
            height: 4px;
            background: linear-gradient(90deg, #B8860B, #D4A84B, #B8860B);
        }

        .module-label {
            margin: 0;
            font-size: 11px;
            color: rgba(255, 255, 255, 0.75);
            text-transform: uppercase;
            letter-spacing: 2.5px;
            font-weight: 500;
        }

        .lesson-title {
            margin: 10px 0 0 0;
            font-size: 28px;
            color: #ffffff;
            font-weight: 700;
            line-height: 1.3;
            position: relative;
        }

        .lesson-meta {
            display: flex;
            gap: 12px;
            margin-top: 20px;
            padding-top: 18px;
            border-top: 1px solid rgba(255, 255, 255, 0.15);
            flex-wrap: wrap;
        }

        .meta-item {
            display: flex;
            align-items: center;
            gap: 6px;
            font-size: 12px;
            color: rgba(255, 255, 255, 0.85);
            background: rgba(255, 255, 255, 0.1);
            padding: 5px 12px;
            border-radius: 4px;
        }

        /* Table of Contents */
        .toc-box {
            background: linear-gradient(135deg, #fafafa 0%, #f5f5f5 100%);
            border-radius: 14px;
            padding: 24px 28px;
            margin-bottom: 35px;
            border: 1px solid #e8e8e8;
        }

        .toc-box .box-label {
            font-weight: 600;
            color: #1e3a8a;
            margin: 0 0 18px 0;
            font-size: 12px;
            text-transform: uppercase;
            letter-spacing: 2px;
            padding-bottom: 12px;
            border-bottom: 1px solid #e0e0e0;
        }

        .toc-list {
            list-style: none;
            margin: 0;
            padding: 0;
            display: grid;
            grid-template-columns: repeat(2, 1fr);
            gap: 8px 24px;
        }

        .toc-list li {
            margin: 0;
        }

        .toc-list a {
            display: flex;
            align-items: center;
            padding: 8px 12px;
            color: #555;
            text-decoration: none;
            font-size: 14px;
            border-radius: 6px;
            transition: all 0.2s ease;
        }

        .toc-list a:hover {
            background: white;
            color: #1e3a8a;
            box-shadow: 0 2px 8px rgba(0, 0, 0, 0.06);
        }

        .toc-list .section-num {
            display: inline-flex;
            align-items: center;
            justify-content: center;
            width: 26px;
            height: 26px;
            background: #1e3a8a;
            color: white;
            font-weight: 600;
            font-size: 11px;
            border-radius: 6px;
            margin-right: 12px;
            flex-shrink: 0;
        }

        /* Learning Objectives */
        .objectives-box {
            background: #eff6ff;
            border: 2px solid #3b82f6;
            border-radius: 14px;
            padding: 30px 35px;
            margin-bottom: 40px;
        }

        .objectives-box .box-label {
            font-weight: 600;
            color: #1e3a8a;
            margin: 0 0 18px 0;
            font-size: 13px;
            text-transform: uppercase;
            letter-spacing: 2px;
            display: flex;
            align-items: center;
            gap: 10px;
        }

        .objectives-box .box-label::before {
            content: 'ðŸŽ¯';
            font-size: 18px;
        }

        .objectives-box ul {
            margin: 0;
            padding-left: 22px;
        }

        .objectives-box li {
            margin-bottom: 14px;
            font-size: 16px;
            line-height: 1.7;
        }

        /* Key Terms Box */
        .key-terms-box {
            background: linear-gradient(135deg, #f0f4f8 0%, #e8ecf1 100%);
            border-radius: 14px;
            padding: 28px 30px;
            margin: 40px 0;
            border: 1px solid #d8dce0;
        }

        .key-terms-box .box-label {
            font-weight: 600;
            color: #1e3a8a;
            margin: 0 0 18px 0;
            font-size: 13px;
            text-transform: uppercase;
            letter-spacing: 2px;
        }

        .terms-grid {
            display: grid;
            grid-template-columns: repeat(auto-fit, minmax(280px, 1fr));
            gap: 16px;
        }

        .term-item {
            background: white;
            padding: 16px 18px;
            border-radius: 10px;
            border-left: 4px solid #3b82f6;
        }

        .term-item .term {
            font-weight: 700;
            color: #1e3a8a;
            font-size: 15px;
            margin: 0 0 6px 0;
        }

        .term-item .definition {
            font-size: 14px;
            color: #555;
            margin: 0;
            line-height: 1.6;
        }

        /* Section Headings */
        h2 {
            font-size: 24px;
            color: #1e3a8a;
            margin: 50px 0 20px 0;
            font-weight: 600;
            position: relative;
            padding-bottom: 12px;
        }

        h2::after {
            content: '';
            position: absolute;
            bottom: 0;
            left: 0;
            width: 60px;
            height: 3px;
            background: #B8860B;
        }

        /* Paragraphs */
        p {
            font-size: 17px;
            margin-bottom: 20px;
            color: #333;
        }

        /* Highlights */
        .highlight {
            background: linear-gradient(180deg, transparent 60%, #FFF59D 60%);
            padding: 0 4px;
            font-weight: 500;
        }

        /* Welcome Box */
        .welcome-box {
            background: linear-gradient(135deg, #eff6ff 0%, #dbeafe 100%);
            padding: 30px 35px;
            border-radius: 14px;
            margin-bottom: 40px;
            border: 1px solid #bfdbfe;
        }

        .welcome-box h3 {
            margin: 0 0 15px 0;
            font-size: 20px;
            color: #1e3a8a;
            font-weight: 600;
        }

        /* Stats Box */
        .stats-box {
            background: linear-gradient(135deg, #1e3a8a 0%, #3b82f6 100%);
            padding: 40px;
            border-radius: 16px;
            margin: 35px 0;
            position: relative;
            overflow: hidden;
        }

        .stats-grid {
            display: grid;
            grid-template-columns: repeat(auto-fit, minmax(140px, 1fr));
            gap: 25px;
            position: relative;
        }

        .stat-item {
            text-align: center;
        }

        .stat-number {
            font-size: 42px;
            font-weight: 700;
            color: white;
            line-height: 1;
            margin-bottom: 8px;
        }

        .stat-label {
            font-size: 13px;
            color: rgba(255, 255, 255, 0.85);
            text-transform: uppercase;
            letter-spacing: 1px;
        }

        /* Case Study */
        .case-study {
            background: linear-gradient(135deg, #f8f9fb 0%, #f0f2f5 100%);
            border-radius: 16px;
            margin: 40px 0;
            overflow: hidden;
            box-shadow: 0 4px 20px rgba(0, 0, 0, 0.06);
        }

        .case-study-header {
            background: linear-gradient(135deg, #1e3a8a 0%, #3b82f6 100%);
            padding: 20px 30px;
            display: flex;
            align-items: center;
            gap: 15px;
        }

        .case-study-header .box-label {
            font-weight: 600;
            color: #ffffff;
            margin: 0;
            font-size: 16px;
        }

        .case-study-content {
            padding: 28px 30px;
        }

        .patient-profile {
            display: flex;
            align-items: center;
            gap: 18px;
            padding: 18px 22px;
            background: white;
            border-radius: 12px;
            margin-bottom: 20px;
            border: 1px solid #e5e5e5;
        }

        .patient-avatar {
            width: 55px;
            height: 55px;
            background: linear-gradient(135deg, #3b82f6, #1e3a8a);
            border-radius: 50%;
            display: flex;
            align-items: center;
            justify-content: center;
            font-size: 24px;
            color: white;
        }

        /* Comparison Table */
        .data-table-container {
            overflow-x: auto;
            margin: 30px 0;
            border-radius: 12px;
            border: 1px solid #e5e5e5;
        }

        table {
            width: 100%;
            border-collapse: collapse;
            font-size: 15px;
            text-align: left;
        }

        th {
            background: #f1f5f9;
            color: #1e3a8a;
            padding: 15px;
            font-weight: 700;
            border-bottom: 2px solid #e2e8f0;
        }

        td {
            padding: 15px;
            border-bottom: 1px solid #f1f5f9;
            color: #444;
        }

        /* Check Understanding */
        .check-understanding {
            background: linear-gradient(135deg, #fdfbf7 0%, #f9f5ed 100%);
            border: 2px solid #B8860B;
            border-radius: 16px;
            padding: 32px;
            margin: 45px 0;
        }

        .check-understanding .box-label {
            font-weight: 600;
            color: #8B6914;
            margin: 0 0 8px 0;
            font-size: 13px;
            text-transform: uppercase;
            letter-spacing: 2px;
        }

        .question-item {
            background: white;
            border-radius: 12px;
            padding: 22px 24px;
            margin-bottom: 16px;
            border: 1px solid #e8e4dc;
            position: relative;
        }

        .reveal-btn {
            background: #1e3a8a;
            color: white;
            border: none;
            padding: 10px 20px;
            border-radius: 8px;
            cursor: pointer;
            font-family: inherit;
        }

        .answer-text {
            display: none;
            font-size: 14px;
            color: #1e3a8a;
            margin: 14px 0 0 0;
            padding: 14px;
            background: #eff6ff;
            border-radius: 8px;
        }

        .answer-text.show {
            display: block;
        }

        /* Takeaways & References */
        .takeaways-box {
            background: #f1f5f9;
            padding: 25px;
            border-radius: 12px;
            margin: 40px 0;
        }

        .references-box {
            background: #f8fafc;
            padding: 25px;
            border-radius: 12px;
            font-size: 14px;
            color: #64748b;
            border: 1px solid #e2e8f0;
        }

        .references-box h4 {
            margin: 0 0 15px 0;
            color: #1e3a8a;
            font-size: 16px;
        }

        /* Footer */
        .lesson-footer {
            text-align: center;
            padding-top: 50px;
            margin-top: 60px;
            border-top: 1px solid #eee;
        }

        .footer-logo {
            max-width: 140px;
            opacity: 0.9;
        }
    </style>
</head>

<body>
    <div class="lesson-container">
        <div class="brand-header">
            <img src="/logoimg/LOGO_ACCREDI.png" alt="AccrediPro Academy" class="brand-logo">
        </div>

        <header class="module-header">
            <p class="module-label">Module 3: Vascular & Mitochondrial Health (V)</p>
            <h1 class="lesson-title">Lesson 3.5: The NAD+ Connection: Fueling the Longevity Engine</h1>
            <div class="lesson-meta">
                <span class="meta-item">28 min read</span>
                <span class="meta-item">Lesson 5 of 6</span>
            </div>
        </header>

        <div class="toc-box">
            <p class="box-label">In This Lesson</p>
            <ul class="toc-list">
                <li><a href="#section1"><span class="section-num">1</span>The NAD+ Biological Blueprint</a></li>
                <li><a href="#section2"><span class="section-num">2</span>NAD+ and Sirtuin Activation</a></li>
                <li><a href="#section3"><span class="section-num">3</span>Vascular Aging & NAD+</a></li>
                <li><a href="#section4"><span class="section-num">4</span>Precursors: NMN vs. NR</a></li>
                <li><a href="#section5"><span class="section-num">5</span>The CD38 "NAD+ Sink"</a></li>
                <li><a href="#section6"><span class="section-num">6</span>Clinical Protocols</a></li>
            </ul>
        </div>

        <div class="objectives-box">
            <p class="box-label">Learning Objectives</p>
            <ul>
                <li>Define the role of NAD+ in cellular energy production and genomic stability.</li>
                <li>Explain the mechanism by which NAD+ activates Sirtuins to improve vascular health.</li>
                <li>Analyze the clinical differences between NAD+ precursors NMN and NR.</li>
                <li>Identify the primary drivers of age-related NAD+ decline, including CD38 expression.</li>
                <li>Develop a lifestyle-first strategy for optimizing the NAD+ pool in aging clients.</li>
            </ul>
        </div>

        <div class="welcome-box">
            <h3>The Currency of Life</h3>
            <p>If mitochondria are the engines of our cells, <span class="highlight">NAD+ (Nicotinamide Adenine Dinucleotide)</span> is the high-octane fuel that allows those engines to run. Without NAD+, every biological processâ€”from heartbeat to DNA repairâ€”would cease instantly. In the context of the V.I.T.A.L.S. Methodâ„¢, NAD+ acts as the bridge between mitochondrial energy production and vascular resilience. As we age, our "fuel tank" empties, leading to the bioenergetic failure we recognize as aging.</p>
        </div>

        <div class="key-terms-box">
            <p class="box-label">ðŸ”¬ Key Terms to Know</p>
            <div class="terms-grid">
                <div class="term-item">
                    <p class="term">NAD+ (Nicotinamide Adenine Dinucleotide)</p>
                    <p class="definition">A critical coenzyme found in all living cells, essential for energy metabolism and DNA repair.</p>
                </div>
                <div class="term-item">
                    <p class="term">Sirtuins (SIRT1-7)</p>
                    <p class="definition">A family of NAD+-dependent proteins that act as metabolic sensors and regulate longevity pathways.</p>
                </div>
                <div class="term-item">
                    <p class="term">PARPs</p>
                    <p class="definition">Enzymes responsible for repairing DNA damage; they consume significant amounts of NAD+ during cellular stress.</p>
                </div>
                <div class="term-item">
                    <p class="term">CD38</p>
                    <p class="definition">An enzyme that increases with age and chronic inflammation, acting as a "sink" that destroys NAD+.</p>
                </div>
            </div>
        </div>

        <h2 id="section1">The NAD+ Biological Blueprint</h2>
        <p>NAD+ exists in two forms: NAD+ (the oxidized form) and NADH (the reduced form). The ratio between these two is a primary indicator of <span class="highlight">metabolic health</span>. While we have previously discussed CoQ10 and PQQ as mitochondrial supports, NAD+ is unique because it serves dual roles: it is both a metabolic cofactor in the Krebs cycle and a signaling molecule for longevity genes.</p>

        <p>A 2021 study published in <em>Nature Aging</em> demonstrated that human NAD+ levels in the skin and brain decline by <span class="highlight">approximately 50% every 20 years</span>. By age 50, most individuals are operating on half the cellular fuel they possessed at age 20. This deficit directly impacts the "V" in V.I.T.A.L.S.â€”Vascular and Mitochondrial Healthâ€”by limiting the cell's ability to respond to oxidative stress and maintain endothelial integrity.</p>

        <div class="stats-box">
            <div class="stats-grid">
                <div class="stat-item">
                    <div class="stat-number">50%</div>
                    <div class="stat-label">Decline by Age 50</div>
                </div>
                <div class="stat-item">
                    <div class="stat-number">500+</div>
                    <div class="stat-label">Enzymatic Reactions</div>
                </div>
                <div class="stat-item">
                    <div class="stat-number">20%</div>
                    <div class="stat-label">ATP Boost via NMN</div>
                </div>
                <div class="stat-item">
                    <div class="stat-number">7</div>
                    <div class="stat-label">Mammalian Sirtuins</div>
                </div>
            </div>
        </div>

        <h2 id="section2">NAD+ and Sirtuin Activation</h2>
        <p>Sirtuins are often called the "guardians of the genome." They are a family of seven proteins that respond to environmental stress (like fasting or exercise) by initiating cellular repair. However, Sirtuins are <span class="highlight">NAD+-dependent</span>. If NAD+ levels are low, Sirtuins remain dormant, regardless of how much you exercise or fast.</p>

        <p>Specifically, SIRT1 and SIRT3 are critical for mitochondrial health. SIRT1 enhances mitochondrial biogenesis (creating new mitochondria) by activating PGC-1Î±, while SIRT3 maintains mitochondrial protein stability. When NAD+ levels are optimized, SIRT1 also promotes the production of <span class="highlight">Nitric Oxide (NO)</span> in the vascular endothelium, directly linking cellular fuel to blood flow and cardiovascular health.</p>

        <h2 id="section3">Vascular Aging & NAD+</h2>
        <p>Vascular aging is characterized by endothelial dysfunction and arterial stiffness. NAD+ plays a pivotal role in preventing this decline through two primary pathways:</p>
        <ol class="content-list">
            <li><strong>Endothelial Protection:</strong> High NAD+ levels maintain SIRT1 activity, which inhibits the pro-inflammatory NF-ÎºB pathway in the blood vessel walls.</li>
            <li><strong>Angiogenesis:</strong> Research (Das et al., 2018) found that restoring NAD+ levels in elderly mice stimulated the growth of new capillaries, effectively "rejuvenating" the blood supply to muscles and organs.</li>
        </ol>

        <div class="data-table-container">
            <table>
                <thead>
                    <tr>
                        <th>Feature</th>
                        <th>Low NAD+ State</th>
                        <th>Optimized NAD+ State</th>
                    </tr>
                </thead>
                <tbody>
                    <tr>
                        <td><strong>Mitochondrial Function</strong></td>
                        <td>High ROS, Low ATP production</td>
                        <td>Efficient oxidative phosphorylation</td>
                    </tr>
                    <tr>
                        <td><strong>DNA Repair</strong></td>
                        <td>Accumulation of mutations (PARP failure)</td>
                        <td>Rapid repair of double-strand breaks</td>
                    </tr>
                    <tr>
                        <td><strong>Vascular Tone</strong></td>
                        <td>Reduced NO, Endothelial stiffness</td>
                        <td>High NO bioavailability, Elasticity</td>
                    </tr>
                    <tr>
                        <td><strong>Inflammation</strong></td>
                        <td>High "Inflammaging" (CD38 high)</td>
                        <td>Modulated immune response</td>
                    </tr>
                </tbody>
            </table>
        </div>

        <h2 id="section4">Precursors: NMN vs. NR</h2>
        <p>The anti-aging industry is currently centered on two primary NAD+ precursors: <span class="highlight">Nicotinamide Mononucleotide (NMN)</span> and <span class="highlight">Nicotinamide Riboside (NR)</span>. While both effectively raise systemic NAD+ levels, they follow slightly different metabolic pathways.</p>

        <p>A 2023 meta-analysis of clinical trials (n=452) found that NMN supplementation (250mgâ€“1000mg/day) consistently improved walking distance and insulin sensitivity in middle-aged and older adults. NR, while also effective, has shown more pronounced results in reducing systemic inflammatory markers like IL-6. For the Longevity Coach, the choice often depends on the clientâ€™s specific "V" goals: NMN for physical performance and vascular flow, NR for neuroprotection and systemic inflammation.</p>

        <div class="case-study">
            <div class="case-study-header">
                <div class="case-study-icon">ðŸ‘¤</div>
                <div>
                    <p class="box-label">Case Study: The "Wall" of Middle-Age Fatigue</p>
                    <p style="color: rgba(255,255,255,0.8); margin:0; font-size:13px;">Bioenergetic Resuscitation</p>
                </div>
            </div>
            <div class="case-study-content">
                <div class="patient-profile">
                    <div class="patient-avatar">M</div>
                    <div class="patient-info">
                        <h4>Marcus, 54</h4>
                        <p>Presenting with: Brain fog, exercise intolerance, and early-stage hypertension.</p>
                    </div>
                </div>
                <p><strong>Intervention:</strong> Marcus implemented a "V" optimization protocol consisting of 500mg Liposomal NMN daily, combined with Zone 2 aerobic training and a 16:8 time-restricted feeding window to naturally stimulate NAD+ salvage pathways.</p>
                <p><strong>Outcomes (12 Weeks):</strong>
                    <ul>
                        <li>15% increase in VO2 Max.</li>
                        <li>Significant reduction in systolic blood pressure (138 mmHg to 124 mmHg).</li>
                        <li>Subjective report of "mental clarity" returning to levels experienced in his 30s.</li>
                    </ul>
                </p>
            </div>
        </div>

        <h2 id="section5">The CD38 "NAD+ Sink"</h2>
        <p>One of the most critical discoveries in longevity science is that the decline of NAD+ isn't just about reduced productionâ€”it's about <span class="highlight">increased destruction</span>. The enzyme CD38 is a voracious consumer of NAD+. As we age, chronic low-grade inflammation (Inflammaging) causes CD38 levels to spike.</p>

        <p>Think of NAD+ like water in a bathtub. Precursors (NMN/NR) turn on the faucet. However, CD38 is like a giant hole in the bottom of the tub. If you don't plug the hole (by reducing inflammation and inhibiting CD38), much of your supplementation is wasted. Natural flavonoids like <span class="highlight">Apigenin</span> (found in parsley and chamomile) and <span class="highlight">Quercetin</span> have been shown to inhibit CD38, making them essential "companion nutrients" in an NAD+ protocol.</p>

        <h2 id="section6">Clinical Protocols for the Longevity Coach</h2>
        <p>When working with clients, the goal is to create a "Multi-Pronged NAD+ Strategy" that addresses both production and consumption:</p>

        <div class="principle-card">
            <p class="principle-title">1. Lifestyle Priming (The Foundation)</p>
            <p class="principle-text">Fasting and exercise activate NAMPT, the enzyme that recycles NAD+ from Nicotinamide. Without these lifestyle triggers, supplementation is less efficient.</p>
        </div>

        <div class="principle-card">
            <p class="principle-title">2. Targeted Supplementation</p>
            <p class="principle-text">NMN (300-600mg) or NR (300-500mg). Liposomal delivery is often preferred to bypass first-pass metabolism in the liver.</p>
        </div>

        <div class="principle-card">
            <p class="principle-title">3. Protecting the Pool</p>
            <p class="principle-text">Include 50mg of Apigenin or 500mg of Quercetin to inhibit CD38 and prevent the "NAD+ Sink" effect.</p>
        </div>

        <div class="check-understanding">
            <p class="box-label">Check Your Understanding</p>
            <p class="box-subtitle">Test your knowledge of NAD+ and longevity pathways.</p>

            <div class="question-item">
                <div class="question-number">1</div>
                <p class="question-text">Why is NAD+ considered essential for Sirtuin activity?</p>
                <button class="reveal-btn" onclick="this.nextElementSibling.classList.toggle('show')">Reveal Answer</button>
                <div class="answer-text">Sirtuins are NAD+-dependent deacetylases. They require NAD+ as a substrate to function; without it, they cannot remove acetyl groups from proteins to regulate DNA repair and mitochondrial health.</div>
            </div>

            <div class="question-item">
                <div class="question-number">2</div>
                <p class="question-text">How does chronic inflammation (Inflammaging) accelerate NAD+ decline?</p>
                <button class="reveal-btn" onclick="this.nextElementSibling.classList.toggle('show')">Reveal Answer</button>
                <div class="answer-text">Inflammation triggers an increase in CD38 expression. CD38 is an enzyme that breaks down NAD+ at an accelerated rate, effectively draining the cellular pool even if production remains stable.</div>
            </div>
        </div>

        <div class="takeaways-box">
            <p class="box-label">Key Takeaways</p>
            <ul>
                <li>NAD+ is a mandatory coenzyme for over 500 enzymatic reactions, including energy production and DNA repair.</li>
                <li>Levels decline by roughly 50% every two decades, driving the bioenergetic failure of aging.</li>
                <li>Sirtuins (longevity genes) are dormant without sufficient NAD+ availability.</li>
                <li>Optimization requires a dual approach: increasing production (NMN/NR/Lifestyle) and decreasing consumption (CD38 inhibition).</li>
                <li>Vascular health is heavily dependent on NAD+ via SIRT1-mediated Nitric Oxide production.</li>
            </ul>
        </div>

        <div class="references-box">
            <h4>References & Further Reading</h4>
            <p>1. Covarrubias et al. (2021). "NAD+ metabolism and its roles in cellular processes during ageing." Nature Reviews Molecular Cell Biology.</p>
            <p>2. Das et al. (2018). "Impairment of an Endothelial NAD+-SIRT1-PGC-1Î± Pathway Is a Reversible Cause of Vascular Aging." Cell.</p>
            <p>3. Yi et al. (2023). "The efficacy and safety of Î²-nicotinamide mononucleotide (NMN) supplementation in healthy middle-aged and older adults: A systematic review." GeroScience.</p>
            <p>4. Sinclair, D.A. (2019). "Lifespan: Why We Age â€“ and Why We Don't Have To." Atria Books.</p>
            <p>5. Camacho-Pereira et al. (2016). "CD38 Dictates Age-Related NAD Decline and Mitochondrial Dysfunction through an SIRT3-Dependent Mechanism." Cell Metabolism.</p>
            <p>6. Rajman et al. (2018). "Therapeutic Potential of NAD-Boosting Molecules: The In Vivo Evidence." Cell Metabolism.</p>
        </div>

        <footer class="lesson-footer">
            <img src="/logoimg/LOGO_ACCREDI.png" alt="AccrediPro Academy" class="footer-logo">
            <p class="brand">AccrediPro Academy: Anti-Aging & Longevity Coach Certification</p>
            <p class="copyright">&copy; 2024 AccrediPro Academy. All rights reserved.</p>
        </footer>
    </div>
</body>

</html>